Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10851
ImmuCell
ICCC
$88.6M
| $149K | ﹤0.01% |
+29,021
| New | +$116K |
2024 Q4
0 quarters
|
|
10852
CALL
CoinShares Bitcoin and Ether ETF
BTF
$16M
| $149K | ﹤0.01% |
2,040
-460
| -18% | -$45K |
2024 Q2
2 quarters
|
|
10853
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$26.4M
| $149K | ﹤0.01% |
+2,997
| New | +$401K |
2024 Q4
0 quarters
|
|
10854
Nuveen Floating Rate Income Fund
JFR
$1.18B
| $149K | ﹤0.01% |
+16,726
| New | +$150K |
2024 Q4
0 quarters
|
|
10855
PUT
Mine Safety
MSA
$6.87B
| $149K | ﹤0.01% |
900
-6,700
| -88% | -$1.15M |
2022 Q1
11 quarters
|
|
10856
CALL
Bioventus
BVS
$864M
| $149K | ﹤0.01% |
14,200
-1,100
| -7% | -$13K |
2023 Q2
6 quarters
|
|
|
SPHL
10857
Springview Holdings
SPHL
$5.13M
| $149K | ﹤0.01% |
+2,870
| New | +$110K |
2024 Q4
0 quarters
|
|
10858
CALL
Acacia Research
ACTG
$427M
| $149K | ﹤0.01% |
34,300
+33,300
| +3,330% | +$151K |
2023 Q2
6 quarters
|
|
10859
CALL
Entrada Therapeutics
TRDA
$215M
| $149K | ﹤0.01% |
8,600
+3,800
| +79% | +$68.8K |
2024 Q2
2 quarters
|
|
10860
VanEck Long Muni ETF
MLN
$655M
| $149K | ﹤0.01% |
+8,311
| New | +$150K |
2024 Q4
0 quarters
|
|
10861
CALL
Kornit Digital
KRNT
$780M
| $149K | ﹤0.01% |
4,800
-1,800
| -27% | -$51.6K |
2019 Q1
23 quarters
|
|
|
BELFB
10862
CALL
Bel Fuse Inc Class B
BELFB
$3.5B
| $148K | ﹤0.01% |
1,800
-7,100
| -80% | -$574K |
2022 Q4
8 quarters
|
|
10863
PUT
Editas Medicine
EDIT
$439M
| $148K | ﹤0.01% |
116,800
+49,500
| +74% | +$126K |
2017 Q1
31 quarters
|
|
|
OLO
10864
PUT
DELISTED
Olo Inc
OLO
| $148K | ﹤0.01% |
19,300
+7,200
| +60% | +$45K |
2024 Q3
1 quarter
|
|
|
CSGS
10865
PUT
DELISTED
CSG Systems International
CSGS
| $148K | ﹤0.01% |
2,900
-6,100
| -68% | -$314K |
2022 Q4
8 quarters
|
|
10866
Teucrium Soybean Fund
SOYB
$45.3M
| $148K | ﹤0.01% |
6,891
+4,799
| +229% | +$103K |
2023 Q3
5 quarters
|
|
10867
US Commodity Index
USCI
$417M
| $148K | ﹤0.01% |
2,243
-12,763
| -85% | -$818K |
2024 Q2
2 quarters
|
|
10868
GrowGeneration
GRWG
$88.4M
| $148K | ﹤0.01% |
87,568
+7,490
| +9% | +$14.3K |
2024 Q3
1 quarter
|
|
10869
Summit State Bank
SSBI
$85.7M
| $148K | ﹤0.01% |
19,370
+5,888
| +44% | +$43K |
2023 Q4
4 quarters
|
|
|
CVGW
10870
PUT
DELISTED
Calavo Growers
CVGW
| $148K | ﹤0.01% |
+5,800
| New | +$158K |
2024 Q4
0 quarters
|
|
10871
Global X Genomics & Biotechnology ETF
GNOM
$96.2M
| $148K | ﹤0.01% |
+3,804
| New | +$160K |
2024 Q4
0 quarters
|
|
10872
Stereotaxis
STXS
$111M
| $148K | ﹤0.01% |
64,752
+10,435
| +19% | +$21.8K |
2020 Q4
16 quarters
|
|
10873
PUT
VanEck Mortgage REIT Income ETF
MORT
$302M
| $148K | ﹤0.01% |
13,900
+8,100
| +140% | +$91.2K |
2022 Q4
8 quarters
|
|
10874
PUT
Rekor Systems
REKR
$45.5M
| $147K | ﹤0.01% |
94,500
+70,500
| +294% | +$73.2K |
2020 Q4
16 quarters
|
|
10875
PUT
Invesco DB Oil Fund
DBO
$291M
| $147K | ﹤0.01% |
10,300
+1,000
| +11% | +$14.5K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.